Published in Psychiatr Q on January 01, 1995
Adrenergic pharmacology and cognition: focus on the prefrontal cortex. Pharmacol Ther (2006) 2.24
Brain fuel metabolism, aging, and Alzheimer's disease. Nutrition (2010) 1.89
The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives. Biochim Biophys Acta (2013) 1.34
fMRI activation during episodic encoding and metacognitive appraisal across the lifespan: risk factors for Alzheimer's disease. Neuropsychologia (2007) 1.02
Bioenergetic medicine. Br J Pharmacol (2014) 0.93
Beta2 adrenergic agonist, clenbuterol, enhances working memory performance in aging animals. Neurobiol Aging (2007) 0.93
Is brain amyloid production a cause or a result of dementia of the Alzheimer's type? J Alzheimers Dis (2010) 0.92
Glucose metabolism in normal aging and Alzheimer's disease: Methodological and physiological considerations for PET studies. Clin Transl Imaging (2013) 0.91
Growing old with epilepsy: the neglected issue of cognitive and brain health in aging and elder persons with chronic epilepsy. Epilepsia (2007) 0.90
Cannabis Abusers Show Hypofrontality and Blunted Brain Responses to a Stimulant Challenge in Females but not in Males. Neuropsychopharmacology (2016) 0.87
Gender differences in aging: cognition, emotions, and neuroimaging studies. Dialogues Clin Neurosci (2002) 0.85
Combined cognitive-psychological-physical intervention induces reorganization of intrinsic functional brain architecture in older adults. Neural Plast (2015) 0.84
Effects of sex and normal aging on regional brain activation during verbal memory performance. Neurobiol Aging (2008) 0.84
Volume of interest-based [18F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study. Neuroimage Clin (2014) 0.84
Bioenergetic dysfunction and inflammation in Alzheimer's disease: a possible connection. Front Aging Neurosci (2014) 0.80
Can Ketones Help Rescue Brain Fuel Supply in Later Life? Implications for Cognitive Health during Aging and the Treatment of Alzheimer's Disease. Front Mol Neurosci (2016) 0.78
One of the most well-established age-related changes in neural activity disappears after controlling for visual acuity. Neuroimage (2016) 0.77
Age-related changes of apolipoprotein D expression in female rat central nervous system with chronic estradiol treatment. Age (Dordr) (2011) 0.76
Association between dopamine D4 receptor polymorphism and age related changes in brain glucose metabolism. PLoS One (2013) 0.76
Differential Fasting Plasma Glucose and Ketone Body Levels in GHRKO versus 3xTg-AD Mice: A Potential Contributor to Aging-Related Cognitive Status? Int J Endocrinol (2017) 0.75
Age-related Impairment of Vascular Structure and Functions. Aging Dis (2017) 0.75
The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry (1982) 10.83
Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab (1996) 9.49
Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. JAMA (2001) 5.13
Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat Neurosci (1998) 4.76
Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry (2001) 4.37
Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry (2001) 4.13
Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse (1993) 4.13
Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease. Neurology (2007) 3.97
Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/poitron-emission tomography (FDG/PET). Proc Natl Acad Sci U S A (2001) 3.86
Three-dimensional structure of rotavirus. J Mol Biol (1988) 3.79
Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature (1997) 3.76
Unmanageable motivation in addiction: a pathology in prefrontal-accumbens glutamate transmission. Neuron (2005) 3.75
Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci (2001) 3.46
The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease. Neuroscience (2000) 3.40
Imaging dopamine's role in drug abuse and addiction. Neuropharmacology (2008) 3.28
Hippocampal formation glucose metabolism and volume losses in MCI and AD. Neurobiol Aging (2001) 3.25
Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals. Am J Psychiatry (1998) 3.02
Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment. Neurobiol Aging (2005) 3.00
Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature (1997) 2.94
Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer's disease. Neurobiol Aging (2000) 2.80
Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease. Neurobiol Aging (1997) 2.68
Fatty and fibroglandular tissue volumes in the breasts of women 20-83 years old: comparison of X-ray mammography and computer-assisted MR imaging. AJR Am J Roentgenol (1997) 2.66
Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease. Neurology (2008) 2.66
Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease. Neurobiol Aging (1997) 2.66
Inhibition of monoamine oxidase B in the brains of smokers. Nature (1996) 2.62
Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes. Diabetologia (2007) 2.60
Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am J Psychiatry (1998) 2.50
Prediction of reinforcing responses to psychostimulants in humans by brain dopamine D2 receptor levels. Am J Psychiatry (1999) 2.49
Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease. Ann Neurol (1998) 2.48
The radiologic prediction of Alzheimer disease: the atrophic hippocampal formation. AJNR Am J Neuroradiol (1993) 2.44
Hippocampal volume losses in minimally impaired elderly. Lancet (1995) 2.26
Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis. Neurology (2005) 2.24
Preliminary evidence for brain complications in obese adolescents with type 2 diabetes mellitus. Diabetologia (2010) 2.20
Long-term frontal brain metabolic changes in cocaine abusers. Synapse (1992) 2.16
Concentration and occupancy of dopamine transporters in cocaine abusers with [11C]cocaine and PET. Synapse (1997) 2.15
Global Deterioration Scale (GDS). Psychopharmacol Bull (1988) 2.14
Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease. Ann N Y Acad Sci (2007) 2.11
Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D(2) receptors. J Pharmacol Exp Ther (1999) 2.11
Decreases in dopamine receptors but not in dopamine transporters in alcoholics. Alcohol Clin Exp Res (1996) 2.09
Altered glucose metabolism in microvessels from patients with Alzheimer's disease. Ann Neurol (1989) 2.08
Neurological impairment in violent schizophrenic inpatients. Am J Psychiatry (1989) 2.07
Early marker for Alzheimer's disease: the atrophic hippocampus. Lancet (1989) 2.02
Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Arch Gen Psychiatry (1995) 2.00
Alzheimer disease: measuring loss of cerebral gray matter with MR imaging. Radiology (1991) 1.92
Food and drug reward: overlapping circuits in human obesity and addiction. Curr Top Behav Neurosci (2012) 1.90
MRI of entorhinal cortex in mild Alzheimer's disease. Lancet (1999) 1.86
Association between age-related decline in brain dopamine activity and impairment in frontal and cingulate metabolism. Am J Psychiatry (2000) 1.85
Association of methylphenidate-induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: implications in addiction. Am J Psychiatry (1999) 1.81
A strategy for removing the bias in the graphical analysis method. J Cereb Blood Flow Metab (2001) 1.79
Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans. J Psychopharmacol (1999) 1.78
Brain monoamine oxidase A inhibition in cigarette smokers. Proc Natl Acad Sci U S A (1996) 1.78
MRI and CSF studies in the early diagnosis of Alzheimer's disease. J Intern Med (2004) 1.77
Fat-cell changes as a mechanism of avascular necrosis of the femoral head in cortisone-treated rabbits. J Bone Joint Surg Am (1977) 1.71
Imaging endogenous dopamine competition with [11C]raclopride in the human brain. Synapse (1994) 1.68
Relationships between regional neuronal loss and neurofibrillary changes in the hippocampal formation and duration and severity of Alzheimer disease. J Neuropathol Exp Neurol (1997) 1.67
CT diagnostic features of Alzheimer disease: importance of the choroidal/hippocampal fissure complex. AJNR Am J Neuroradiol (1990) 1.62
Addiction changes orbitofrontal gyrus function: involvement in response inhibition. Neuroreport (2001) 1.55
Poverty and the economic effects of TB in rural China. Int J Tuberc Lung Dis (2006) 1.55
Effects of route of administration on cocaine induced dopamine transporter blockade in the human brain. Life Sci (2000) 1.54
Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers. Am J Psychiatry (2001) 1.52
Effects of crack cocaine on neurocognitive function. Psychiatry Res (1996) 1.51
Hippocampal atrophy in normal aging. An association with recent memory impairment. Arch Neurol (1993) 1.49
Age-related marrow conversion in the proximal metaphysis of the femur: evaluation with T1-weighted MR imaging. Radiology (1998) 1.47
Functional magnetic resonance imaging of human brain activity in a verbal fluency task. J Neurol Neurosurg Psychiatry (1998) 1.45
Leptin attenuates cardiac contraction in rat ventricular myocytes. Role of NO. Hypertension (2000) 1.42
Longitudinal CSF isoprostane and MRI atrophy in the progression to AD. J Neurol (2007) 1.41
High-dose administration of nonionic contrast media: a retrospective review. Radiology (1996) 1.41
Fungal virus capsids, cytoplasmic compartments for the replication of double-stranded RNA, formed as icosahedral shells of asymmetric Gag dimers. J Mol Biol (1994) 1.39
Volumetric analysis of the pre-frontal regions: findings in aging and schizophrenia. Psychiatry Res (2001) 1.38
Dopamine transporters decrease with age. J Nucl Med (1996) 1.36
Reproducibility of repeated measures of carbon-11-raclopride binding in the human brain. J Nucl Med (1993) 1.36
PET evaluation of the dopamine system of the human brain. J Nucl Med (1996) 1.35
Protruding aortic atheromas predict stroke in elderly patients undergoing cardiopulmonary bypass: experience with intraoperative transesophageal echocardiography. J Am Coll Cardiol (1992) 1.34
Hippocampal atrophy in early Alzheimer's disease: anatomic specificity and validation. Psychiatr Q (1993) 1.33
Hippocampal formation size predicts declining memory performance in normal aging. Neurology (1996) 1.33
Topography of cross-sectional and longitudinal glucose metabolic deficits in Alzheimer's disease. Pathophysiologic implications. Arch Neurol (1992) 1.33